sq-18506 has been researched along with Chagas Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chapman, WL; Hanson, WL; Kinnamon, KE; Steck, EA | 1 |
| Cover, B; Gaborak, M; Gutteridge, WE | 1 |
2 other study(ies) available for sq-18506 and Chagas Disease
| Article | Year |
|---|---|
In search of anti-Trypanosoma cruzi drugs: new leads from a mouse model.
Topics: 5-Amino-3-((5-nitro-2-furyl)vinyl)-1,2,4-oxadiazole; Aminoquinolines; Animals; Chagas Disease; Disease Models, Animal; Male; Mice; Nifurtimox; Onium Compounds; Structure-Activity Relationship; Trityl Compounds; Trypanocidal Agents; Trypanosoma cruzi | 1977 |
Comparative study of SQ 18 506 with other nitroheterocyclic compounds on experimental Chagas' disease.
Topics: 5-Amino-3-((5-nitro-2-furyl)vinyl)-1,2,4-oxadiazole; Animals; Chagas Disease; Culture Techniques; Drug Evaluation, Preclinical; Female; Male; Metronidazole; Mice; Mice, Inbred A; Nitrofurans; Nitroimidazoles | 1978 |